Centenial Surgical informs about outcome of board meeting

14 Feb 2018 Evaluate

Centenial Surgical has informed that Board of Directors of the Company at their meeting held on Wednesday, February 14, 2018 at 12.00 noon approved Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2017 as per Regulation 33 of SEBI (LODR) Regulations, 2015 and approval of re-appointment of  Anuradha Kashikar (DIN : 00804831), as an Executive Director and Chief Financial Officer (CFO) of the Company.

The above information is a part of company’s filings submitted to BSE.


Centenial Surgical Share Price

144.95 16.50 (12.85%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Poly Medicure 3162.70
Hemant Surgical Inds 143.00
Nureca Ltd. 298.40
Prevest Denpro 563.05
Centenial Surgical 144.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.